Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of (Deficit) Equity

v3.22.2.2
Condensed Consolidated Statements of (Deficit) Equity - USD ($)
$ in Thousands
Total
Total Stockholders’ (Deficit) Equity
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interests
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Series B Preferred Stock
Total Stockholders’ (Deficit) Equity
Series B Preferred Stock
Preferred Stock
Beginning balance (in shares) at Dec. 31, 2020     9,703,874     224,429 562     1,875,748
Beginning balance at Dec. 31, 2020 $ 16,849 $ 14,918 $ 97 $ 234,061 $ (260,867) $ 1,931 $ 453     $ 41,174
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount               $ 22 $ 22 $ 22
Adjustment for noncontrolling interest in operating partnership 0 16   16   $ (16)        
Conversion of Operating Partnership units to Common Stock (in shares)     2,864     (2,864)        
Conversion of Operating Partnership units to Common Stock 0 9   9   $ (9)        
Dividends and distributions (2,273) (2,273)     (2,273)          
Net (Loss) Income (4,034) (4,049)     (4,049) $ 15        
Deemed contribution related to preferred stock redemption 4,389 4,389     4,389          
Ending balance (in shares) at Mar. 31, 2021     9,706,738     221,565 562     1,875,748
Ending balance at Mar. 31, 2021 14,953 13,032 $ 97 234,086 (262,800) $ 1,921 $ 453     $ 41,196
Beginning balance (in shares) at Dec. 31, 2020     9,703,874     224,429 562     1,875,748
Beginning balance at Dec. 31, 2020 16,849 14,918 $ 97 234,061 (260,867) $ 1,931 $ 453     $ 41,174
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 454                  
Deemed contribution related to preferred stock redemption 5,040                  
Ending balance (in shares) at Sep. 30, 2021     9,713,787     217,088 562     1,872,448
Ending balance at Sep. 30, 2021 11,276 9,339 $ 97 234,199 (266,577) $ 1,937 $ 453     $ 41,167
Beginning balance (in shares) at Mar. 31, 2021     9,706,738     221,565 562     1,875,748
Beginning balance at Mar. 31, 2021 14,953 13,032 $ 97 234,086 (262,800) $ 1,921 $ 453     $ 41,196
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 22 22               $ 22
Adjustment for noncontrolling interest in operating partnership 0 15   15   $ (15)        
Conversion of Operating Partnership units to Common Stock (in shares)     3,676     (3,676)        
Conversion of Operating Partnership units to Common Stock 0 18   18   $ (18)        
Dividends and distributions (2,189) (2,189)     (2,189)          
Net (Loss) Income (3,067) (3,067)     (3,067)          
Deemed contribution related to preferred stock redemption 651 651     651          
Ending balance (in shares) at Jun. 30, 2021     9,710,414     217,889 562     1,875,748
Ending balance at Jun. 30, 2021 10,370 8,482 $ 97 234,119 (267,405) $ 1,888 $ 453     $ 41,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 21 21               $ 21
Adjustment for noncontrolling interest in operating partnership 0 5   5   $ (5)        
Conversion of Operating Partnership units to Common Stock (in shares)     801     (801)        
Conversion of Operating Partnership units to Common Stock 0 3   3   $ (3)        
Conversion of Series B Preferred Stock to Common Stock (in shares)     2,572             (3,300)
Conversion of Series B Preferred Stock to Common Stock 0     72           $ (72)
Dividends and distributions (2,198) (2,198)     (2,198)          
Net (Loss) Income 3,083 3,026     3,026 $ 57        
Deemed contribution related to preferred stock redemption 0                  
Ending balance (in shares) at Sep. 30, 2021     9,713,787     217,088 562     1,872,448
Ending balance at Sep. 30, 2021 11,276 9,339 $ 97 234,199 (266,577) $ 1,937 $ 453     $ 41,167
Beginning balance (in shares) at Dec. 31, 2021     9,720,532     215,343 562     1,872,448
Beginning balance at Dec. 31, 2021 3,802 1,861 $ 97 234,229 (274,107) $ 1,941 $ 453     $ 41,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 22 22               $ 22
Conversion of Series B Preferred Stock to Common Stock (in shares)     2,561             (4,105)
Conversion of Series B Preferred Stock to Common Stock 0     90           $ (90)
Dividends and distributions (2,264) (2,264)     (2,264)          
Net (Loss) Income (4,576) (4,580)     (4,580) $ 4        
Ending balance (in shares) at Mar. 31, 2022     9,723,093     215,343 562     1,868,343
Ending balance at Mar. 31, 2022 (3,016) (4,961) $ 97 234,319 (280,951) $ 1,945 $ 453     $ 41,121
Beginning balance (in shares) at Dec. 31, 2021     9,720,532     215,343 562     1,872,448
Beginning balance at Dec. 31, 2021 3,802 1,861 $ 97 234,229 (274,107) $ 1,941 $ 453     $ 41,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 438                  
Deemed contribution related to preferred stock redemption 0                  
Ending balance (in shares) at Sep. 30, 2022     9,793,494     144,942 562     2,301,337
Ending balance at Sep. 30, 2022 55,159 (9,776) $ 98 234,956 (288,546) $ 64,935 $ 453     $ 43,263
Beginning balance (in shares) at Mar. 31, 2022     9,723,093     215,343 562     1,868,343
Beginning balance at Mar. 31, 2022 (3,016) (4,961) $ 97 234,319 (280,951) $ 1,945 $ 453     $ 41,121
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount   22           22   $ 22
Adjustment for noncontrolling interest in operating partnership 0 470   470   $ (470)        
Conversion of Operating Partnership units to Common Stock (in shares)     69,620     (69,620)        
Conversion of Operating Partnership units to Common Stock 0 159 $ 1 158   $ (159)        
Paid-in-kind interest, issuance of Series B Preferred Stock (in shares)                   432,994
Paid-in-kind interest, issuance of Series B Preferred Stock 2,099 2,099               $ 2,099
Dividends and distributions (2,264) (2,264)     (2,264)          
Net (Loss) Income (53) (52)     (52) $ (1)        
Ending balance (in shares) at Jun. 30, 2022     9,792,713     145,723 562     2,301,337
Ending balance at Jun. 30, 2022 (3,212) (4,527) $ 98 234,947 (283,267) $ 1,315 $ 453     $ 43,242
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount   21           $ 21   $ 21
Adjustment for noncontrolling interest in operating partnership 0 7   7   $ (7)        
Conversion of Operating Partnership units to Common Stock (in shares)     781     (781)        
Conversion of Operating Partnership units to Common Stock 0 2 $ 0 2   $ (2)        
Noncontrolling interests assumed from the acquisition [1] 64,845         64,845        
Dividends and distributions (3,489) (2,264)     (2,264) (1,225)        
Net (Loss) Income (3,006) (3,015)     (3,015) $ 9        
Deemed contribution related to preferred stock redemption 0                  
Ending balance (in shares) at Sep. 30, 2022     9,793,494     144,942 562     2,301,337
Ending balance at Sep. 30, 2022 $ 55,159 $ (9,776) $ 98 $ 234,956 $ (288,546) $ 64,935 $ 453     $ 43,263
[1] See Notes 1, 2 and 3 of the Notes to the Condensed Consolidated Financial Statements for further details.